Charles River Laboratories International (CRL) Cash from Investing Activities (2009 - 2025)

Charles River Laboratories International (CRL) has reported Cash from Investing Activities for 17 consecutive years, with -$92.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash from Investing Activities fell 21.95% year-over-year to -$92.8 million; the TTM figure through Dec 2025 stood at -$209.3 million (up 14.59% YoY), while the FY2025 annual figure was -$209.3 million, up 14.59% from the prior year.
• Cash from Investing Activities came in at -$92.8 million for Q4 2025 at Charles River Laboratories International, down from -$33.7 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $44.4 million in Q4 2022, with the low at -$954.2 million in Q2 2021.
• Average Cash from Investing Activities over 5 years is -$153.2 million, with a median of -$82.7 million recorded in 2023.
• Across the five-year window, Cash from Investing Activities slumped 3233.31% in 2021 and surged 376.88% in 2022, its largest moves.
• Year by year, Cash from Investing Activities stood at $9.3 million in 2021, then soared by 376.88% to $44.4 million in 2022, then plunged by 637.08% to -$238.4 million in 2023, then soared by 68.07% to -$76.1 million in 2024, then declined by 21.95% to -$92.8 million in 2025.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$92.8 million, -$33.7 million, and -$37.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.